首页 > 最新文献

Indian Journal of Peritoneal dialysis最新文献

英文 中文
Peritoneal dialysis – ideal renal replacement therapy during coronavirus (COVID-19) pandemic 腹膜透析——冠状病毒(COVID-19)大流行期间理想的肾脏替代疗法
Pub Date : 1900-01-01 DOI: 10.4103/IOPD.IOPD_5_20
J. Eapen
Peritoneal dialysis has an important role to play in the ongoing coronavirus pandemic. It can help in maintaining social distancing goals in dialysis patients and hence should be considered as first line renal replacement therapy (RRT) in all incident ESRD patients. There is emerging interest in the role of PD for the treatment of Acute Kidney Injury especially in the setting of overburdened hemodialysis/CRRT services in the ICU. This article discusses the role of PD in managing critically ill COVID patients.
腹膜透析在持续的冠状病毒大流行中发挥着重要作用。它有助于维持透析患者的社会距离目标,因此应将其视为所有ESRD患者的一线肾脏替代疗法(RRT)。PD在急性肾损伤治疗中的作用正在引起人们的兴趣,特别是在ICU超负荷血液透析/CRRT服务的情况下。本文讨论PD在重症COVID患者管理中的作用。
{"title":"Peritoneal dialysis – ideal renal replacement therapy during coronavirus (COVID-19) pandemic","authors":"J. Eapen","doi":"10.4103/IOPD.IOPD_5_20","DOIUrl":"https://doi.org/10.4103/IOPD.IOPD_5_20","url":null,"abstract":"Peritoneal dialysis has an important role to play in the ongoing coronavirus pandemic. It can help in maintaining social distancing goals in dialysis patients and hence should be considered as first line renal replacement therapy (RRT) in all incident ESRD patients. There is emerging interest in the role of PD for the treatment of Acute Kidney Injury especially in the setting of overburdened hemodialysis/CRRT services in the ICU. This article discusses the role of PD in managing critically ill COVID patients.","PeriodicalId":442296,"journal":{"name":"Indian Journal of Peritoneal dialysis","volume":"13 2","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133204301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Randomized controlled trial to compare the tolerability and efficacy of treatment with Icodextrin 7.5% versus Dextrose 2.5% in chronic peritoneal dialysis patients with high/high average solute transport characteristics and low residual renal function 随机对照试验,比较7.5%伊科糊精和2.5%葡萄糖治疗慢性腹膜透析患者高/高平均溶质转运特征和低残余肾功能的耐受性和疗效
Pub Date : 1900-01-01 DOI: 10.4103/IOPD.IOPD_5_19
V. Sood, R. Grover, Vivek Kumar, S. Singh, K. Gupta
Aim: Comparison of tolerability and efficacy of treatment with icodextrin vs. dextrose 2.5% amongst high risk cohort of chronic peritoneal dialysis patients (high/high average solute transport characteristics and low residual renal function) over 3 months. Study Design and Methodology: The study was an open-label, comparative, prospective, randomized controlled trial, conducted at department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. A total of 349 end stage renal disease patients on chronic peritoneal dialysis were screened for eligibility over a period of 6 months and 41 patients with high / high average solute transport characteristics and low residual renal function were randomized to receive either icodextrin 7.5% solution or 2.5% dextrose solution in long dwell. Patients were assessed for adequacy of peritoneal dialysis (creatinine & urea clearance), peritoneal membrane transport characteristics including solute clearance (standard peritoneal equilibration test), body composition, total body water, fat mass and fat free mass (using whole body tetrapolar bioimpedance analyzer) at baseline and at the end of 3 months. Statistical Analysis: Continuous variables were compared with independent samples paired t test if normally distributed, or with Mann–Whitney U test if the distribution was skewed. Categorical variables were analyzed with Chi-square test or Fisher exact test as appropriate. Pearson's correlation coefficient was calculated between different quantitative variables. Paired t test and Wilcoxon signed-rank test were used for within-group comparisons. Repeated measure ANOVA was used to compare bioelectrical impedance between intervention groups. Results: The study has shown that use of icodextrin based continuous ambulatory peritoneal dialysis resulted in better ultrafiltration and improved solute clearance when compared to 2.5% dextrose based peritoneal dialysis in a select cohort of patients having high/high average transporter characteristics with poor residual renal function, however, it didn't significantly alter total body water and failed to translate into improvements in either patient's or physician's assessment of global health of response to therapy atleast at 3 months. Conclusions: Although use of icodextrin based peritoneal dialysis solution for long dwell resulted in significant improvement in solute clearance and ultrafiltration nevertheless failed to translate into better hydration status or subjective improvement scores atleast at 3 months.
目的:比较慢性腹膜透析患者高风险队列(高/高平均溶质转运特征和低残余肾功能)3个月以上的icodextrin与葡萄糖2.5%治疗的耐受性和疗效。研究设计和方法:该研究是一项开放标签、比较、前瞻性、随机对照试验,在印度昌迪加尔医学教育与研究研究生院肾内科进行。在为期6个月的时间里,对349名接受慢性腹膜透析的终末期肾病患者进行了筛选,并对41名具有高/高平均溶质转运特征和低残余肾功能的患者进行了随机分组,分别接受7.5%的icodextrin溶液或2.5%的葡萄糖溶液长期治疗。在基线和3个月结束时评估患者的腹膜透析充分性(肌酐和尿素清除率)、腹膜运输特征(包括溶质清除率(标准腹膜平衡试验)、身体组成、全身水分、脂肪量和无脂肪量(使用全身四极生物阻抗分析仪)。统计分析:连续变量正态分布采用独立样本配对t检验,偏态分布采用Mann-Whitney U检验。分类变量分析采用卡方检验或Fisher精确检验。计算不同数量变量之间的Pearson相关系数。组内比较采用配对t检验和Wilcoxon符号秩检验。采用重复测量方差分析比较干预组间的生物电阻抗。结果:然而,该研究表明,与2.5%葡萄糖为基础的腹膜透析相比,在一组具有高/高平均转运蛋白特征且残余肾功能较差的患者中,使用icodextrin为基础的连续动态腹膜透析可获得更好的超滤效果和更高的溶质清除率。它没有显著改变总体内水分,也没有转化为患者或医生对至少3个月的治疗反应的总体健康评估的改善。结论:尽管长期使用基于醋酸糊精的腹膜透析液可显著改善溶质清除率和超滤,但至少在3个月后未能转化为更好的水合状态或主观改善评分。
{"title":"Randomized controlled trial to compare the tolerability and efficacy of treatment with Icodextrin 7.5% versus Dextrose 2.5% in chronic peritoneal dialysis patients with high/high average solute transport characteristics and low residual renal function","authors":"V. Sood, R. Grover, Vivek Kumar, S. Singh, K. Gupta","doi":"10.4103/IOPD.IOPD_5_19","DOIUrl":"https://doi.org/10.4103/IOPD.IOPD_5_19","url":null,"abstract":"Aim: Comparison of tolerability and efficacy of treatment with icodextrin vs. dextrose 2.5% amongst high risk cohort of chronic peritoneal dialysis patients (high/high average solute transport characteristics and low residual renal function) over 3 months. Study Design and Methodology: The study was an open-label, comparative, prospective, randomized controlled trial, conducted at department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. A total of 349 end stage renal disease patients on chronic peritoneal dialysis were screened for eligibility over a period of 6 months and 41 patients with high / high average solute transport characteristics and low residual renal function were randomized to receive either icodextrin 7.5% solution or 2.5% dextrose solution in long dwell. Patients were assessed for adequacy of peritoneal dialysis (creatinine & urea clearance), peritoneal membrane transport characteristics including solute clearance (standard peritoneal equilibration test), body composition, total body water, fat mass and fat free mass (using whole body tetrapolar bioimpedance analyzer) at baseline and at the end of 3 months. Statistical Analysis: Continuous variables were compared with independent samples paired t test if normally distributed, or with Mann–Whitney U test if the distribution was skewed. Categorical variables were analyzed with Chi-square test or Fisher exact test as appropriate. Pearson's correlation coefficient was calculated between different quantitative variables. Paired t test and Wilcoxon signed-rank test were used for within-group comparisons. Repeated measure ANOVA was used to compare bioelectrical impedance between intervention groups. Results: The study has shown that use of icodextrin based continuous ambulatory peritoneal dialysis resulted in better ultrafiltration and improved solute clearance when compared to 2.5% dextrose based peritoneal dialysis in a select cohort of patients having high/high average transporter characteristics with poor residual renal function, however, it didn't significantly alter total body water and failed to translate into improvements in either patient's or physician's assessment of global health of response to therapy atleast at 3 months. Conclusions: Although use of icodextrin based peritoneal dialysis solution for long dwell resulted in significant improvement in solute clearance and ultrafiltration nevertheless failed to translate into better hydration status or subjective improvement scores atleast at 3 months.","PeriodicalId":442296,"journal":{"name":"Indian Journal of Peritoneal dialysis","volume":"33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132357484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An unusual complication of CAPD technique: Lesson to be learnt CAPD技术的一个不寻常的并发症:吸取的教训
Pub Date : 1900-01-01 DOI: 10.4103/IOPD.IOPD_1_19
Muzamil Ahmed, Manjusha Yadla
Continuous Ambulatory Peritoneal Dialysis is a recommended mode of renal replacement therapy in those with vascular access failures. Complications of Surgical placement of catheter and Percutaneous technique by Nephrologist are well described. Complications may occur during the procedure or after the procedure. During the placement of the catheter, hollow viscus perforation is known to occur. Patients are given instructions of using laxative , emptying bladder before surgery in order to avoid bladder or bowel injury. Bladder perforation is one of the rare complication of CAPD technique.It is expected to occur commonly with rigid catheters than the soft catheters used in CAPD. Herein we report a case of bladder perforation during the procedure of placement of percutaneous CAPD catheterization.
连续非卧床腹膜透析是血管通路失败患者肾替代治疗的推荐模式。手术置管和经皮肾科技术的并发症被很好地描述。并发症可能发生在手术过程中或手术后。在放置导管期间,已知会发生中空的内脏穿孔。术前指导患者使用泻药,排空膀胱,以避免膀胱或肠道损伤。膀胱穿孔是CAPD技术的罕见并发症之一。与CAPD中使用的软导管相比,刚性导管通常会发生这种情况。在此,我们报告一例膀胱穿孔在过程中放置经皮CAPD导尿。
{"title":"An unusual complication of CAPD technique: Lesson to be learnt","authors":"Muzamil Ahmed, Manjusha Yadla","doi":"10.4103/IOPD.IOPD_1_19","DOIUrl":"https://doi.org/10.4103/IOPD.IOPD_1_19","url":null,"abstract":"Continuous Ambulatory Peritoneal Dialysis is a recommended mode of renal replacement therapy in those with vascular access failures. Complications of Surgical placement of catheter and Percutaneous technique by Nephrologist are well described. Complications may occur during the procedure or after the procedure. During the placement of the catheter, hollow viscus perforation is known to occur. Patients are given instructions of using laxative , emptying bladder before surgery in order to avoid bladder or bowel injury. Bladder perforation is one of the rare complication of CAPD technique.It is expected to occur commonly with rigid catheters than the soft catheters used in CAPD. Herein we report a case of bladder perforation during the procedure of placement of percutaneous CAPD catheterization.","PeriodicalId":442296,"journal":{"name":"Indian Journal of Peritoneal dialysis","volume":"223 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131598362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare case of early Burkholderia cepacia peritonitis in a chronic ambulatory peritoneal dialysis patient 一例罕见的早期洋葱伯克霍尔德菌腹膜炎在慢性流动腹膜透析病人
Pub Date : 1900-01-01 DOI: 10.4103/IOPD.IOPD_6_20
S. Sahoo, A. Achra, B. Muthukumar, Shiwangi Sharma
Continuous ambulatory peritoneal dialysis (CAPD) is one of the preferred forms of renal replacement therapy. However, peritonitis is the leading cause of morbidity and mortality associated with CAPD. Here, we report a case of Burkholderia cepacia peritonitis which required combination of antibiotics and catheter removal for its treatment.
连续动态腹膜透析(CAPD)是肾脏替代治疗的首选形式之一。然而,腹膜炎是与CAPD相关的发病率和死亡率的主要原因。在此,我们报告一例洋葱伯克霍尔德菌腹膜炎,需要联合抗生素和导管切除治疗。
{"title":"A rare case of early Burkholderia cepacia peritonitis in a chronic ambulatory peritoneal dialysis patient","authors":"S. Sahoo, A. Achra, B. Muthukumar, Shiwangi Sharma","doi":"10.4103/IOPD.IOPD_6_20","DOIUrl":"https://doi.org/10.4103/IOPD.IOPD_6_20","url":null,"abstract":"Continuous ambulatory peritoneal dialysis (CAPD) is one of the preferred forms of renal replacement therapy. However, peritonitis is the leading cause of morbidity and mortality associated with CAPD. Here, we report a case of Burkholderia cepacia peritonitis which required combination of antibiotics and catheter removal for its treatment.","PeriodicalId":442296,"journal":{"name":"Indian Journal of Peritoneal dialysis","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122153810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
History of peritoneal dialysis 腹膜透析史
Pub Date : 1900-01-01 DOI: 10.4103/IOPD.IOPD_2_20
S. Yusuf
>Peritoneal Dialysis is now an accepted mode of renal replacement therapy. The story of its development is a fascinating scientific journey of pioneers who have worked tirelessly to develop and extend the application of this technique which now plays such an important part in the treatment of patients with ESKD. This article reviews the milestones in the history of innovation of this life saving treatment in an attempt to understand to the hopes and ideas of our predecessors and build on them into the future to make peritoneal dialysis a more effective, safer, and inexpensive therapy for ESKD.
腹膜透析是目前公认的肾替代治疗模式。其发展的故事是一个引人入胜的科学之旅的先驱,他们不知疲倦地工作,以开发和扩展该技术的应用,现在在ESKD患者的治疗中起着如此重要的作用。本文回顾了腹膜透析这一救命疗法创新历史上的里程碑,试图理解前人的希望和想法,并以此为基础,使腹膜透析成为一种更有效、更安全、更廉价的ESKD治疗方法。
{"title":"History of peritoneal dialysis","authors":"S. Yusuf","doi":"10.4103/IOPD.IOPD_2_20","DOIUrl":"https://doi.org/10.4103/IOPD.IOPD_2_20","url":null,"abstract":">Peritoneal Dialysis is now an accepted mode of renal replacement therapy. The story of its development is a fascinating scientific journey of pioneers who have worked tirelessly to develop and extend the application of this technique which now plays such an important part in the treatment of patients with ESKD. This article reviews the milestones in the history of innovation of this life saving treatment in an attempt to understand to the hopes and ideas of our predecessors and build on them into the future to make peritoneal dialysis a more effective, safer, and inexpensive therapy for ESKD.","PeriodicalId":442296,"journal":{"name":"Indian Journal of Peritoneal dialysis","volume":"109 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116923022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unusual organisms causing continuous ambulatory peritoneal dialysis peritonitis 引起持续性腹膜透析腹膜炎的不寻常生物体
Pub Date : 1900-01-01 DOI: 10.4103/IOPD.IOPD_1_20
Sankarakumar GaneshAravind, A. Rohit, N. Gopalakrishnan, J. Dhanapriya, T. Dineshkumar, R. Sakthirajan, N. Malathy, T. Balasubramaniyan, A. Maasila
Peritonitis is an important cause for morbidity and mortality in Continuous Ambulatory Peritoneal Dialysis (CAPD) patients. There is an emerging trend towards unusual organism causing CAPD peritonitis. We report our experience with unusual organisms and its impact on survival. We had 43 CAPD peritonitis episodes, out of which, six were due to unusual organisms. Although five patients responded to antibiotic therapy, one lost her CAPD access (catheter). Clinically, peritonitis caused by unusual organism is similar to that caused by other pathogens. Adherence to diligent hygienic practices while handling catheter and bag is most important in avoiding such peritonitis episodes.
腹膜炎是连续门诊腹膜透析(CAPD)患者发病和死亡的重要原因。有一种新的趋势,即引起CAPD腹膜炎的异常生物。我们报告我们与不寻常的生物体的经验及其对生存的影响。我们有43例CAPD腹膜炎发作,其中6例是由不寻常的微生物引起的。虽然5名患者对抗生素治疗有反应,但1名患者失去了CAPD通道(导管)。临床上,由异常生物引起的腹膜炎与其他病原体引起的腹膜炎相似。在处理导尿管和袋时,坚持勤奋的卫生习惯是避免此类腹膜炎发作的最重要因素。
{"title":"Unusual organisms causing continuous ambulatory peritoneal dialysis peritonitis","authors":"Sankarakumar GaneshAravind, A. Rohit, N. Gopalakrishnan, J. Dhanapriya, T. Dineshkumar, R. Sakthirajan, N. Malathy, T. Balasubramaniyan, A. Maasila","doi":"10.4103/IOPD.IOPD_1_20","DOIUrl":"https://doi.org/10.4103/IOPD.IOPD_1_20","url":null,"abstract":"Peritonitis is an important cause for morbidity and mortality in Continuous Ambulatory Peritoneal Dialysis (CAPD) patients. There is an emerging trend towards unusual organism causing CAPD peritonitis. We report our experience with unusual organisms and its impact on survival. We had 43 CAPD peritonitis episodes, out of which, six were due to unusual organisms. Although five patients responded to antibiotic therapy, one lost her CAPD access (catheter). Clinically, peritonitis caused by unusual organism is similar to that caused by other pathogens. Adherence to diligent hygienic practices while handling catheter and bag is most important in avoiding such peritonitis episodes.","PeriodicalId":442296,"journal":{"name":"Indian Journal of Peritoneal dialysis","volume":"38 4","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114131293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian Journal of Peritoneal dialysis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1